ReviewJournal of clinical medicine research2018

SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.

Elamin Abdelgadir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.